India to United Kingdom: Ertapenem Export Trade Route
India has recorded 11 verified shipments of Ertapenem exported to United Kingdom, representing a combined trade value of $1.4M USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $129.3K USD. The leading Indian exporter is EUGIA PHARMA SPECIALITIES LIMITED, which accounts for 100% of total export value with 10 shipments worth $1.4M USD. On the buying side, MILPHARM LIMITED, ALLOGA UK, is the largest importer in United Kingdom with $567.8K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United Kingdom Ertapenem corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $1.4M USD. The route is dominated by EUGIA PHARMA SPECIALITIES LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's ertapenem manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $129.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (0%) and air (100%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October-December, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 29.0%, placing it at rank #5 among India's top ertapenem export destinations globally.
On the import side, key buyers of Indian ertapenem in United Kingdom include MILPHARM LIMITED, ALLOGA UK,, MILPHARM LIMITED ALLOGA UKAMBER PARK, MILPHARM LIMITED, ALLOGA UK and 3 others. MILPHARM LIMITED, ALLOGA UK, is the single largest importer with 4 shipments valued at $567.8K USD.
